United Community Banks Inc provides a wide range of financial products and services to the commercial, retail, governmental, educational, energy, health care and real estate sectors... Show more
UCB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where UCB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where UCB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 18, 2025. You may want to consider a long position or call options on UCB as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for UCB just turned positive on November 07, 2025. Looking at past instances where UCB's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UCB advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UCB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for UCB entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UCB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock slightly worse than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.032) is normal, around the industry mean (1.108). P/E Ratio (12.115) is within average values for comparable stocks, (18.002). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.167). Dividend Yield (0.032) settles around the average of (0.036) among similar stocks. P/S Ratio (3.647) is also within normal values, averaging (5.164).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a regional bank
Industry RegionalBanks
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LSRCX | 1.82 | 0.06 | +3.41% |
| Lord Abbett Small Cap Value C | |||
| QRSVX | 43.27 | 1.16 | +2.75% |
| FPA Queens Road Small Cap Value Inv | |||
| BPLEX | 11.10 | 0.16 | +1.46% |
| Boston Partners Long/Short Equity Inv | |||
| FAZYX | 15.29 | 0.15 | +0.99% |
| Fidelity Advisor Multi-Asset Income M | |||
| JUEAX | 27.41 | 0.26 | +0.96% |
| JPMorgan US Equity A | |||
A.I.dvisor indicates that over the last year, UCB has been closely correlated with FNB. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if UCB jumps, then FNB could also see price increases.
| Ticker / NAME | Correlation To UCB | 1D Price Change % | ||
|---|---|---|---|---|
| UCB | 100% | +2.62% | ||
| FNB - UCB | 92% Closely correlated | +2.95% | ||
| FULT - UCB | 91% Closely correlated | +4.00% | ||
| UBSI - UCB | 91% Closely correlated | +4.11% | ||
| WSFS - UCB | 91% Closely correlated | +2.96% | ||
| FFBC - UCB | 91% Closely correlated | +3.21% | ||
More | ||||